Abstract
Subjective risk perception, perceived impact of Huntington’s disease (HD), perceived benefits and barriers of predictive testing and personality characteristics of persons withdrawing from the predictive test programme for HD and of siblings of test applicants were studied in a mailed survey. The belief that important decisions do not need to depend on a test result and the anticipated inability to cope with a bad result played an important role in the decision not to be tested. Nevertheless half of the group who ever considered testing, still planned to undergo a test in the future. A comparison of tested and untested persons revealed that the first group is more likely to overestimate the risk than the second group, but that both groups did not significantly differ from each other regarding anxiety, ego strength and coping strategies. An intrafamilial analysis of tested and untested siblings confirmed these findings. The problems during data collection and the reasons for the dropout are an illustration of the avoidant behaviour regarding HD and the predictive test in many individuals and families.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Harper P: Huntington’s disease. London, Saunders, 1996.
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulson I, Bonilla E, Martin JB: A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 1983;306:234–238.
Huntington’s disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993;72: 1–20.
International Huntington Association and World Federation of Neurology: Guidelines for the molecular genetics predictive test in Huntington’s disease. Neurology 1994;44:1533–1536.
Evers-Kiebooms G: Predictive testing for Huntington’s disease in Belgium. J Psychosom Obstet Gynaecol 1990;11:61–72.
Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Cassiman JJ, Cloostermans T, Demyttenaere K, Dom R, Fryns JP, Van den Berghe H: Predictive testing for Huntington’s disease: Risk perception, reasons for testing and psychological profile of test applicants. Genet Couns 1995;6:1–13.
Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Cassiman JJ, Cloostermans T, Demyttenaere K, Dom R, Fryns JP, Van den Berghe H: Prediction of psychological functioning one year after the predictive test for Huntington’s disease and impact of the test result on reproductive decision making. J Med Gen 1996;33:737–743.
Bloch M, Fahy M, Fox S, Hayden MR: Predictive testing for Huntington disease. II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Gen 1989; 32:217–224.
Craufurd D, Dodge A, Kerzin-Storrar L, Harris R: Uptake of presymptomatic predictive testing for Huntington’s disease. Lancet 1989;ii: 603–605.
Tibben A, Niermeijer RM, Roos RC, Vegter-Vandervlis M, Frets PG, Van Ommen GJ, Van de Kamp JJ, Verhage F: Understanding the low uptake of presymptomatic DNA-testing for Huntington’s disease. Lancet 1992;340:1416.
Tyler A, Ball D, Craufurd D: Presymptomatic testing for Huntington’s disease in the United Kingdom. Br Med J 1992;304:1593–1596.
Wiggins S, Whyte P, Huggins M, Adam S, Theilman J, Bloch M, Sheps SB, Schechter MT, Hayden MR: The psychological consequences of predictive testing for Huntington’s disease. N Engl J Med 1992;327:1401–1405.
Quaid KA, Morris M: Reluctance to undergo predictive testing: The case of Huntington disease. Am J Med Gen 1993;45:41–45.
Codori AM, Hanson R, Brandt J: Self-selection in predictive testing for Huntington’s disease. Am J Med Gen 1994;54:167–173.
Kessler S: Predictive testing for Huntington disease: A psychologist’s view. Am J Med Genet 1994;54:161–166.
Rosenstock IM: The health belief model and preventive health behavior. Health Educ Monogr 1974;2:354–386.
Janz NK, Becker MH: The health belief model: A decade later. Health Educ Q 1984; 11:1–47.
Orbell S, Sheeran P: Health psychology and uptake of preventive health services: A review of 30 years’ research on cervical screening. Psychol Health 1993;8:417–433.
Leventhal H, Safer MA, Panagis DM: The impact of communications on the self-regulation of health beliefs, decisions and behavior. Health Educ 1983;10:3–29.
Barron F: An ego-strength scale which predicts response to psychotherapy. Cons Psychol 1953; 17:327–333.
Van der Steenstraten I, Tibben A, Roos RA, Van de Kamp JJ, Niermeijer MF: Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. Am J Hum Genet 1994;55:618–625.
Shaw MW: Testing for the Huntington gene: A right to know, a right not to know or a duty to know? Am J Med Gen 1987;26:243–246.
De Wert G: Predictive testing for Huntington disease and the right not to know. Some ethical reflections; in Evers-Kiebooms G, Fryns JP, Cassiman JJ, Van den Berghe H (eds): Psychosocial Aspects of Genetic Counseling. March of Dimes, Birth Defects. New York, Wiley-Liss, 1992, vol 28, pp 133–138.
van der Ploeg HM, Defares PB, Spielberger CD: Handleiding bij de zelfbeoordelingsvragenlijst: Een Nederlandstalige bewerking van de Spielberger State Trait Anxiety Inventory. Lisse, Swets & Zeitlinger, 1980.
Graham JR: The MMPI. A Practical Guide. New York, Oxford University Press, 1987.
Schreurs PJ, Van de Willige G, Teilegen B, Brosschoot JF: De Utrechtse Coping Lijst. Omgaan met Problemen en gebeurtenissen. Lisse, Swets & Zeitlinger, 1988.
Siegel S, Castellan NJ: Nonparametric statistics for the behavioral sciences, ed 2. New York, McGraw-Hill, 1988.
Miller S: Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease. Cancer 1995;76:167–177.
Miller S, Brody DS, Summerton J: Styles of coping with threat: Implications for health. J Pers Soc Psychol 1988;54:142–148.
Kessler S: Psychological aspects of genetic counseling. VII. Thoughts on directiveness. J Genet Couns 1992;1:9–17.
Lamport AT: Presymptomatic testing for Huntington chorea: Ethical and legal issues. Am J Med Genet 1987;26:307–314.
Lazarus RS: The costs and benefits of denial; in Breznitz S (ed): The Denial of Stress. New York, International Universities Press, 1983, pp 1–30.
Tibben A: What is knowledge but grieving? On psychological effects of presymptomatic DNA-testing for Huntington’s disease; thesis, Rotterdam, 1993.
Weinstein ND: Optimistic biases about personal risks. Science 1989;246:806–820.
Norem JK, Cantor N: Defensive pessimism: harnessing anxiety and motivation. J Pers Soc Psychol 1986;51:1208–1217.
Cantor N, Norem JK: Defensive pessimism and stress coping. Soc Cogn 1989;7:92–112.
Kessler S, Bloch M: Social system responses to Huntington disease. Fam Process 1989;28:59–68.
Glew R, Huson SM, Rosser E, Jones L, Klimes I: Presymptomatic tests for Huntington’s disease: Factors influencing the decision not to test during pretest counselling. Poster presented at the 5th European Meeting on Psychosocial Aspects of Genetics, Rome, 1996.
Evers-Kiebooms G, Swerts A, Cassiman J J, Van den Berghe H: The motivation of at risk individuals and their partners in deciding for or against predictive testing for Huntington’s disease. Clin Genet 1989;35:29–40.
Jacopini AG, D’Amico R, Frontali M, Vivona G: Attitudes of persons at risk and their partners toward predictive testing; in Evers-Kiebooms G, Fryns JP, Cassiman JJ, Van den Berghe H (eds): Psychosocial Aspects of Genetic Counseling. March of Dimes, Birth Defects. New York, Wiley-Liss, 1992, vol 28, pp 113–117.
Simpson SA, Besson J, Alexander D, Allan K, Johnston AW: One hundred requests for predictive testing for Huntington’s disease. Clin Genet 1992;41:326–330.
Hans MB, Koeppen AH: Huntington’s chorea. Its impact on the spouse. J Nerv Ment Dis 1980;168:209–214.
Bloch M, Hayden MR: Opinion: Predictive testing for Huntington disease in childhood: Challenges and implications. Am J Hum Gen 1990;46:1–4.
Evers-Kiebooms G, Swerts A, Van den Berghe H: Partners of Huntington patients: Implications of the disease and opinions about predictive testing and prenatal diagnosis. Genet Couns 1990;1:151–159.
Kessler S: The spouse in the Huntington disease family. Fam Syst Med 1993; 11:191–199.
Kessler S: Forgotten person in the Huntington disease family. Am J Med Gen 1993;48:145–150.
Demyttenaere K, Evers-Kiebooms G, Decruyenaere M: Pitfalls in counseling for predictive testing in Huntington disease; in Evers-Kiebooms G, Fryns JP, Cassiman JJ, Van den Berghe H (eds): Psychosocial Aspects of Genetic Counseling. March of Dimes, Birth Defects. New York, Wiley-Liss, 1992, vol 28, pp 105–112.
Fox S, Bloch M, Fahy M, Hayden MR: Predictive testing for Huntington disease. I. Description of a pilot project in British Columbia. Am J Med Genet 1989;32:211–216.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A. et al. Non-Participation in Predictive Testing for Huntington’s Disease: Individual Decision-Making, Personality and Avoidant Behaviour in the Family. Eur J Hum Genet 5, 351–363 (1997). https://doi.org/10.1007/BF03405943
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1007/BF03405943
